Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 20;9(8):1773.
doi: 10.3390/microorganisms9081773.

Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19

Daniela Pasero  1   2 , Andrea Pasquale Cossu  2 , Pierpaolo Terragni  1   2
Affiliations
Review

Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19

Daniela Pasero et al. Microorganisms. .

Abstract

It is known that bacterial infections represent a common complication during viral respiratory tract infections such as influenza, with a concomitant increase in morbidity and mortality. Nevertheless, the prevalence of bacterial co-infections and secondary infections in critically ill patients affected by coronavirus disease 2019 (COVID-19) is not well understood yet. We performed a review of the literature currently available to examine the incidence of bacterial secondary infections acquired during hospital stay and the risk factors associated with multidrug resistance. Most of the studies, mainly retrospective and single-centered, highlighted that the incidence of co-infections is low, affecting about 3.5% of hospitalized patients, while the majority are hospital acquired infections, developed later, generally 10-15 days after ICU admission. The prolonged ICU hospitalization and the extensive use of broad-spectrum antimicrobial drugs during the COVID-19 outbreak might have contributed to the selection of pathogens with different profiles of resistance. Consequently, the reported incidence of MDR bacterial infections in critically ill COVID-19 patients is high, ranging between 32% to 50%. MDR infections are linked to a higher length of stay in ICU but not to a higher risk of death. The only risk factor independently associated with MDR secondary infections reported was invasive mechanical ventilation (OR 1.062; 95% CI 1.012-1.114), but also steroid therapy and prolonged length of ICU stay may play a pivotal role. The empiric antimicrobial therapy for a ventilated patient with suspected or proven bacterial co-infection at ICU admission should be prescribed judiciously and managed according to a stewardship program in order to interrupt or adjust it on the basis of culture results.

Keywords: COVID-19; SARS-CoV-2; critically ill patients; hospital acquired infection; multi-drug resistance; secondary bacterial infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Timing of infections’ development during ICU stay.
Figure 2
Figure 2
Flow diagram of the literature selection process for the present article.
See this image and copyright information in PMC

References

    1. Klein E.Y., Monteforte B., Gupta A., Jiang W., May L., Hsieh Y.H., Dugas A. The frequency of influenza and bacterial coinfection: A systematic review and meta-analysis. Influenza Other Respir. Viruses. 2016;10:394–403. doi: 10.1111/irv.12398. - DOI - PMC - PubMed
    1. Rice T.W., Rubinson L., Uyeki T.M., Vaughn F.L., John B.B., Miller R.R., 3rd, Higgs E., Randolph A.G., Smoot B.E., Thompson B.T., et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit. Care Med. 2012;40:1487–1498. doi: 10.1097/CCM.0b013e3182416f23. - DOI - PMC - PubMed
    1. Shah N.S., Greenberg J.A., McNulty M.C., Gregg K.S., Riddell J.t., Mangino J.E., Weber D.M., Hebert C.L., Marzec N.S., Barron M.A., et al. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013–2014. J. Clin. Virol. 2016;80:12–19. doi: 10.1016/j.jcv.2016.04.008. - DOI - PMC - PubMed
    1. Martin-Loeches I., Sanchez-Corral A., Diaz E., Granada R.M., Zaragoza R., Villavicencio C., Albaya A., Cerda E., Catalan R.M., Luque P., et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139:555–562. doi: 10.1378/chest.10-1396. - DOI - PubMed
    1. Alhazzani W., Moller M.H., Arabi Y.M., Loeb M., Gong M.N., Fan E., Oczkowski S., Levy M.M., Derde L., Dzierba A., et al. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Med. 2020;46:854–887. doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed

LinkOut - more resources